Aplastic anemia and paroxysmal nocturnal hemoglobinuria: a follow-up study of the glycosylphosphatidylinositol-anchored proteins defect.

[1]  J. Freyssinet,et al.  Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. , 1999, Blood.

[2]  H. Esperou,et al.  Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria , 1999, British journal of haematology.

[3]  G. Socié.  Recent advances in paroxysmal nocturnal hemoglobinuria. From the biology to the clinic. , 1997, Hematology and cell therapy.

[4]  W. Rosse.  Paroxysmal Nocturnal Hemoglobinuria as a Molecular Disease , 1997, Medicine.

[5]  J. Mary,et al.  Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors , 1996, The Lancet.

[6]  C. Wittwer,et al.  Syngeneic bone marrow transplantation without conditioning in a patient with paroxysmal nocturnal hemoglobinuria: in vivo evidence that the mutant stem cells have a survival advantage. , 1996, Blood.

[7]  F. Sigaux,et al.  Aplastic anaemia and paroxysmal nocturnal haemoglobinuria: a study of the GPI‐anchored proteins on human platelets , 1996, British journal of haematology.

[8]  C. Miller,et al.  Resolution of Budd‐Chiari syndrome following bone marrow transplantation for paroxysmal nocturnal haemoglobinuria , 1996, British journal of haematology.

[9]  K. Pulford,et al.  The novel monoclonal antibody By114 helps detect the early emergence of a paroxysmal nocturnal hemoglobinuria clone in aplastic anemia. , 1995, Experimental hematology.

[10]  S M Lewis,et al.  Natural history of paroxysmal nocturnal hemoglobinuria. , 1995, The New England journal of medicine.

[11]  R. Schmidt,et al.  Glycosylphosphatidylinositol (GPI)‐anchored surface antigens in the allogeneic activation of T cells * , 1995, Clinical and experimental immunology.

[12]  T. Chuhjo,et al.  Quality of hematologic recovery in patients with aplastic anemia following cyclosporine therapy. , 1995, Experimental hematology.

[13]  F. Locatelli,et al.  Antilymphocyte globulin, cyclosporin, and granulocyte colony- stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party , 1995 .

[14]  F. Sigaux,et al.  Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. , 1995, Blood.

[15]  H. Heimpel,et al.  A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. , 1995, Experimental hematology.

[16]  R. Schmidt,et al.  Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia , 1994 .

[17]  R. Storb,et al.  Marrow transplantation for paroxysmal nocturnal hemoglobinuria , 1992, American journal of hematology.